Fetal alcohol spectrum disorders and fetal alcohol syndrome: the state of the art and new diagnostic tools

https://doi.org/10.1016/S0378-3782(13)70013-6Get rights and content

Summary

Ethanol consumption during pregnancy is a widespread problem which is increasing in the generation of young women. Gestational alcohol consumption causes fetal exposure to this teratogen and is associated with the onset of fetal alcohol spectrum disorders (FASD) including fetal alcohol syndrome (FAS). FASD and FAS can lead to several physical, cognitive and behavioral disabilities, whose early diagnosis is of primary importance to perform primary prevention with total abstinence from alcohol during pregnancy and secondary prevention in newborns and children for a proper follow up to reduce risk of secondary consequences.

In recent years significant efforts have been made to understand the underlying mechanisms of this disease and to identify objective biological and instrumental diagnostic tools, such as exposure biomarkers in neonatal meconium and advanced magnetic resonance imaging. Nonetheless, further studies are still needed to implement our knowledge on fetal effects of ethanol, and multidisciplinary actions are necessary to raise awareness among women of childbearing age about the danger of consuming even small amounts of ethanol during pregnancy.

References (22)

  • L Morini et al.

    Liquid chromatography with tandem mass spectrometric detection for the measurement of ethyl glucuronide and ethyl sulfate in meconium: new biomarkers of gestational ethanol exposure?

    Ther Drug Monit

    (2008)
  • Cited by (61)

    • Meconium analysis as a promising diagnostic tool for monitoring fetal exposure to toxic substances: Recent trends and perspectives

      2018, TrAC - Trends in Analytical Chemistry
      Citation Excerpt :

      Currently, it is very difficult to precisely estimate the prevalence of FAS and FASD, because there are no worldwide data available regarding this issue. However, it has been determined that the smallest prevalence of disorders associated with alcohol consumption during pregnancy is in the USA, where FAS is diagnosed in 0.5–2.0 per 1000 live infants, and in Canada, where FAS and FASD are observed in 1–3 and 9 per 1000 live births, respectively [17]. A worse situation is found in Europe.

    • Is post exposure prevention of teratogenic damage possible: Studies on diabetes, valproic acid, alcohol and anti folates in pregnancy: Animal studies with reflection to human

      2018, Reproductive Toxicology
      Citation Excerpt :

      Alcohol-induced birth defects are a major cause of teratogenesis [129]. Symptoms of fetal alcohol spectrum disorders (FASD) include unique facial features, neurocognitive defects, growth retardation (low weight and height), central nervous symptoms abnormalities manifested by cognitive and behavioral abnormalities [129,130]. The most recent research suggests that the prevalence of fetal alcohol spectrum disorder in the US ranges from 31.1 to 98.5 per 1000 children [131].

    • Maternal hair testing to disclose self-misreporting in drinking and smoking behavior during pregnancy

      2018, Alcohol
      Citation Excerpt :

      Despite public health efforts to eliminate or reduce the consumption of tobacco and alcohol during pregnancy, recent international studies indicate that a significant number of pregnant women continue to consume tobacco and a high number of alcoholic beverages during gestation, worldwide (Blanquet, Leger, Gerbaud, & Vendittelli, 2016; Mårdby, Lupattelli, Hensing, & Nordeng, 2017; Pichini, Busardò, Ceccanti, Tarani, & Pacifici, 2017). Whereas prenatal exposure to tobacco can cause reversible transient alterations in exposed newborns, this is not the case of prenatal exposure to ethyl alcohol, which causes permanent disabilities (Crighton et al., 2016; Memo et al., 2013). The results of our study illustrate the importance of using objective measures to document tobacco and alcohol consumption during gestation and to disclose the real proportion of the phenomenon; this is in agreement with the study of Shisler et al. (2017), which considers more intensive prospective self-reporting measures and biological assays as a viable and superior alternative to single item self-report measures.

    View all citing articles on Scopus
    View full text